The U.S. Food and Drug Administration (FDA) has expanded the market clearance for the Collaboration Live teleultrasound technology from Philips.
Collaboration Live is an integrated, diagnostic-quality teleultrasound platform that lets clinicians talk, text, screen-share, and transfer control to remote colleagues in real-time. The platform allows clinicians to collaborate in real-time with colleagues in order to complete image acquisition and diagnosis, regardless of location.
Collaboration Live is available on Philips Ultrasound Systems EPIQ and Affiniti. The additional FDA clearance covers new functions to help increase diagnostic confidence on compatible clients, including iOS, Android, the Chrome web browser, and Windows.
The teleultrasound platform is applicable in any area of medicine, such as breast imaging and hepatology, where ultrasound can provide important diagnostic information, the company said.
